Aptose biosciences stock news
Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. View real- time stock prices and stock quotes for a full financial overview. 22 Mar 2020 Real-time trade and investing ideas on Aptose Biosciences Inc APTO from the largest community of traders and investors. Get breaking news and analysis on Aptose Biosciences Inc. (APTO) stock, price quote and chart, trading and investing tools.
APS.TO - Aptose Biosciences Stock Price - Barchart.com
Nov 06, 2019 · Aptose Biosciences Inc. annual stock financials by MarketWatch. View the latest APTO financial statements, income statements and financial ratios. Aptose Biosciences, Inc. (APTO): Price and ... - Stock News Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. The company was founded in 1986 and is based in Mississauga, Canada. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing. APTO Aptose Biosciences Inc — Stock Price ... - StockTwits
APTO Stock Analysis: Price, Forecast, and News
Feb 12, 2020 · (RTTNews) - Shares of Aptose Biosciences Inc. (APTO), which closed Tuesday's trading at a new yearly high of $7.66, have gained 35 percent so far this year. Company News and Releases - Aptose Biosciences Inc., APTO ... News Headlines for Aptose Biosciences Inc. Friday, Jan 17, 2020. Aptose Biosciences stock price target raised to $8 from $6 at Oppenheimer MarketWatch. 07:30 AM ET. Tuesday, Dec 10, 2019. Aptose Biosciences maintained as buy at Canaccord MarketWatch. 02:04 PM ET. Friday, Jan 25, 2019. Aptose Biosciences, Inc. (APTO) Stock Price, Quote ... Aptose Reports Results for the Fourth Quarter and Full Year 2019. Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today announced financial results for the year and three months ended December 31, 2019 and reported on corporate developments. APS:Toronto Stock Quote - Aptose Biosciences Inc ... Stock analysis for Aptose Biosciences Inc (APS:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
7 Mar 2020 Aptose Biosciences Inc. (APTO) is priced at $8.10 after the most recent trading session. At the very opening of the session, the stock price was
APTO - Aptose Biosciences Summary, Stock Quote and News ... Jan 01, 2010 · Aptose Biosciences (NASDAQ: APTO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on APTO:NASDAQ CM Stock Quote - Aptose Biosciences Inc ...
Aptose Biosciences, Inc. (APTO) Quote Overview » News » Aptose Biosciences, Inc. (APTO) Zacks News Zacks News Factors to Know Ahead of Talos Energy's (TALO) Q4 Earnings
View detailed stock price information for Aptose Biosciences Inc. [APS] from TMXmoney including charting and last 25 trades. 17 Mar 2020 On Monday, shares of Aptose Biosciences Inc. (NASDAQ:APTO) marked $4.74 per share versus a previous $5.25 closing price. With having a Also, analysts rated the stock as a buy with a price target of $9. In forward-looking thoughts, $9 is a very optimistic number to put on a stock that currently doesn't
Also, analysts rated the stock as a buy with a price target of $9. In forward-looking thoughts, $9 is a very optimistic number to put on a stock that currently doesn't The Aptose Biosciences stock price is 6.170 USD today. Will Aptose Biosciences stock price grow / rise / go up? Yes. The APTO stock price can go up from 6.170 See Aptose Biosciences price target based on 6 analysts offering 12 month price targets for Aptose Biosciences in the last 3 months. The average price target is